Почетна › Мозгове туморске промене › Тексас › Houston
Kliničke studije za Мозгове туморске промене u gradu Houston, TX
37 studija za Мозгове туморске промене traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Тражи се учесникФаза 2
- UT MD Anderson Cancer Center, Houston
A Phase I Clinical Study of YN003 in the Treatment of Glioma
Тражи се учесникФаза 1
- The University of Texas MD Anderson Cancer Center, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Тражи се учесник
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Тражи се учесникОпсервациона студија
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Тражи се учесник
- MD Anderson Cancer Center, Houston
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Тражи се учесникФаза 2
- University of Texas MD Anderson Cancer Center, Houston
Mapping of Human Cognition
Тражи се учесник
- The University of Texas Health Science Center at Houston, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Тражи се учесникФаза 2
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Тражи се учесникФаза 1/2
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Тражи се учесникФаза 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
Тражи се учесникФаза 2
- The University of Texas MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Тражи се учесникФаза 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Тражи се учесникФаза 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Тражи се учесникФаза 2
- M D Anderson Cancer Center, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Тражи се учесникФаза 1
- MD Anderson Cancer Center, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Тражи се учесникФаза 2
- Texas Children's Hospital, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Тражи се учесникОпсервациона студија
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
Тражи се учесникОпсервациона студија
- MD Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- MD Anderson Cancer Center - University of Texas, Houston
Targeted Pediatric High-Grade Glioma Therapy
Тражи се учесникОпсервациона студија
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Тражи се учесникФаза 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Тражи се учесникФаза 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Тражи се учесникФаза 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Тражи се учесникФаза 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Тражи се учесникФаза 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Тражи се учесникФаза 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Тражи се учесникФаза 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Тражи се учесникОпсервациона студија
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
Тражи се учесникФаза 2
- M D Anderson Cancer Center, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Тражи се учесникФаза 1
- M D Anderson Cancer Center, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Тражи се учесникФаза 2
- Texas Children's Hospital, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Тражи се учесникОпсервациона студија
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Тражи се учесникФаза 2
- M D Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Тражи се учесник
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Тражи се учесникФаза 1/2
- MD Anderson, Houston
Studije za Мозгове туморске промене u drugim gradovima
- Boston, MA29 студија
- New York City, NY25 студија
- Washington, DC21 студија
- Los Angeles, CA17 студија
- Durham, NC15 студија
- Miami, FL14 студија
- Chicago, IL12 студија
- Rochester, MN12 студија
- St. Louis, MO12 студија
- Cleveland, OH11 студија
- Columbus, OH11 студија
- Seattle, WA11 студија
Ostale studije u gradu Houston
- Немалоклетни карцином плућа143 студија
- Рак дојке126 студија
- Рак (све врсте)124 студија
- Колоректални карцином101 студија
- Метастатски карцином100 студија
- Рак јајника90 студија
- Akutna mijeloidna leukemija88 студија
- Рак плућа78 студија
- Рак простате73 студија
- Карцином ендометријума69 студија
- Меланом61 студија
- Рак панкреаса59 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.